<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://ep.bmj.com">
<title>Education &#x26; Practice Online First</title>
<link>http://ep.bmj.com</link>
<description>Education &#x26; Practice RSS Feed -- Online First</description>
<prism:eIssn>1743-0593</prism:eIssn>
<prism:publicationName>Archives of Disease in Childhood - Education and Practice</prism:publicationName>
<prism:issn>1743-0585</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2026-330927v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-330240v2?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2026-330753v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2026-330459v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2026-330429v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2026-330673v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2026-330424v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329848v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-330118v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-330136v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329806v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2024-328166v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-330107v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329421v2?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329226v3?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329875v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2024-328290v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-328850v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-330235v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329864v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-330172v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329841v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329397v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329863v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329134v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329132v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329133v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329549v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329192v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-328955v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329811v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329173v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329120v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329352v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329360v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-328557v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329423v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329469v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329142v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2024-328251v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329737v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329503v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2025-329478v1?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2024-328409v2?rss=1" />
  <rdf:li rdf:resource="http://ep.bmj.com/cgi/content/short/archdischild-2024-327804v2?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif" />
</channel>
<image rdf:about="http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif">
<title>Archives of Disease in Childhood - Education and Practice</title>
<url>http://hwmaint.ep.bmj.com/misc/home/ADC_95x60.gif</url>
<link>http://ep.bmj.com</link>
</image>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2026-330927v1?rss=1">
<title><![CDATA[Implementing a 'special educational needs transition checklist for young people with complex disability]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2026-330927v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Summary</st><p>The first holistic transition checklist in the UK, designed specifically to address the wider multidisciplinary needs of young people with special educational needs (SEN), was co-produced with young people and their parents/carers.</p></sec><sec id="s2"><st>The problem</st><p>Transition is the purposeful, planned movement of adolescents and young adults with chronic health conditions from child-centred to adult healthcare services. For young people with SEN, transition can present additional challenges, as they often have complex, individualised needs requiring coordinated multidisciplinary input across services. In England, over 1.7 million pupils (20%) are identified as having SEN, with 5% having an Education, Health and Care Plan indicating complex needs.<cross-ref type="bib" refid="R1">1</cross-ref> More broadly, around 12% of UK children have a disability.<cross-ref type="bib" refid="R2">2</cross-ref> Given the complexity of need within this population, well-coordinated and person-centred transition planning is essential to ensure continuity of care and optimise long-term outcomes. Structured approaches that incorporate young people&rsquo;s perspectives can help achieve...]]></description>
<dc:creator><![CDATA[Ashley, D., Ng, I. H. X., Khosravi, S. L., Parish, E., Palanyiaya, H.]]></dc:creator>
<dc:date>2026-06-30T09:00:14-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2026-330927</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2026-330927</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Implementing a 'special educational needs transition checklist for young people with complex disability]]></dc:title>
<prism:publicationDate>2026-06-30</prism:publicationDate>
<prism:section>QUALITY IMPROVEMENT SHORT REPORT</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-330240v2?rss=1">
<title><![CDATA[Delivery room respiratory care: a quality improvement project to reduce preterm intubations]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-330240v2?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Summary</st><p>Implementation of early delivery room continuous positive airway pressure (CPAP) and delivery room less invasive surfactant administration (LISA) to reduce intubation rates in preterm neonates in a tertiary neonatal unit.</p></sec><sec id="s2"><st>The problem</st><p>The National Neonatal Audit Programme (NNAP) data identified that rates of bronchopulmonary dysplasia (BPD) in our unit were around 10% above the national average.<cross-ref type="bib" refid="R1">1</cross-ref> A retrospective review of local practice demonstrated high delivery room (DR) intubation rates in infants born before 32 weeks&rsquo; gestation. As mechanical ventilation is a recognised modifiable risk factor for BPD, these findings highlighted an opportunity to improve early respiratory management.<cross-ref type="bib" refid="R2">2 3</cross-ref><cross-ref type="bib" refid="R3"></cross-ref></p></sec><sec id="s3"><st>Aims</st><p>The overall aim of the project was to optimise early non-invasive respiratory support for preterm neonates born at &lt;32 weeks&rsquo; gestation through DR CPAP and DR LISA. The primary outcome measure was DR intubation rate, with secondary outcomes including exposure to invasive ventilation during the first...]]></description>
<dc:creator><![CDATA[Lakshmipathy, N., Spierson, H.]]></dc:creator>
<dc:date>2026-06-29T23:43:05-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-330240</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-330240</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Delivery room respiratory care: a quality improvement project to reduce preterm intubations]]></dc:title>
<prism:publicationDate>2026-06-29</prism:publicationDate>
<prism:section>QUALITY IMPROVEMENT SHORT REPORT</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2026-330753v1?rss=1">
<title><![CDATA[Neonate with 'rocker-bottom feet: what to do when it is not Edwards syndrome]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2026-330753v1?rss=1</link>
<description><![CDATA[<p>Neonates born with congenital vertical talus (&lsquo;rocker-bottom foot&rsquo;) are challenging to diagnose and manage. The immediate management is generally based on assessing for Edwards syndrome (trisomy 18) or other similar severe life-limiting chromosomal disorders when there are dysmorphic features suggestive of a genetic syndrome, and no clear neurological focus such as a neural tube defect or spinal muscular atrophy disorder. Often the initial fluorescent in situ hybridisation genetic testing is reported as normal, appearing to exclude a trisomy diagnosis. We use two similar neonatal case scenarios with different diagnoses to discuss the next steps in genetic testing and the use of microarray, karyotyping and whole exome sequencing tools in managing these complex cases.</p>]]></description>
<dc:creator><![CDATA[Morrison, P. J., Harris, C., Mccarthy, C., Galway, N., Thompson, D.]]></dc:creator>
<dc:date>2026-06-23T09:00:21-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2026-330753</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2026-330753</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Problem solving in clinical practice]]></dc:subject>
<dc:title><![CDATA[Neonate with 'rocker-bottom feet: what to do when it is not Edwards syndrome]]></dc:title>
<prism:publicationDate>2026-06-23</prism:publicationDate>
<prism:section>PROBLEM SOLVING IN CLINICAL PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2026-330459v1?rss=1">
<title><![CDATA[Breaking the heat: managing steroid refractory warm autoimmune haemolytic anaemia]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2026-330459v1?rss=1</link>
<description><![CDATA[<p>This article describes a case of warm autoimmune haemolytic anaemia (w-AIHA) in a 16-month-old refractory to first-line treatment. W-AIHA typically responds to systemic corticosteroids. Here, management proved challenging with re-emergence of haemolysis during initial steroid course. Rituximab offered a turning point, demonstrating the utility of targeted anti-CD20 antibody therapy in achieving a sustained haematological response. The patient&rsquo;s clinical course was not without further complications potentially attributable to treatments administered. This paper reviews the management of w-AIHA, beyond steroid therapy, with an additional focus on supportive care measures.</p>]]></description>
<dc:creator><![CDATA[Clifton, E., McCool, N., Mitchell, B., Mark, C.]]></dc:creator>
<dc:date>2026-06-12T09:00:25-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2026-330459</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2026-330459</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Problem solving in clinical practice]]></dc:subject>
<dc:title><![CDATA[Breaking the heat: managing steroid refractory warm autoimmune haemolytic anaemia]]></dc:title>
<prism:publicationDate>2026-06-12</prism:publicationDate>
<prism:section>PROBLEM SOLVING IN CLINICAL PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2026-330429v1?rss=1">
<title><![CDATA[Peripheral precocious puberty due to inadvertent exposure to topical oestradiol gel and review of the literature]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2026-330429v1?rss=1</link>
<description><![CDATA[<sec><st>Introduction</st><p>Topical oestradiol gel is now widely used in hormone replacement therapy (HRT), but the risk of inadvertent secondary transfer to children is under-recognised. While accidental exposure to testosterone gels has been documented, oestradiol gel transfer as a cause of precocious puberty in prepubertal girls is rare.</p><p>We undertook a 20-year literature review and discuss the case of a 5-year-old girl presented with Tanner stage 3 breast development, pubic hair stage 2, growth acceleration and mood changes. Laboratory evaluation revealed markedly elevated oestradiol levels with suppressed gonadotrophins, consistent with peripheral precocious puberty. Bone age was advanced by 4 years 6 months. Imaging, karyotype, endocrine and dermatology investigations excluded central precocious puberty, ovarian or adrenal tumours and McCune-Albright syndrome. History, previously not disclosed, revealed daily co-sleeping with her mother, who had been applying oestradiol gel to her upper arms for 18 months as part of HRT. No other oestrogen sources were identified. Maternal oestradiol gel was discontinued and replaced with a transdermal patch. The child&rsquo;s oestradiol levels normalised and pubertal signs regressed over subsequent months.</p><p>This review highlights a rare but important cause of peripheral precocious puberty due to unintentional transfer of topical oestradiol gel through routine parent-child contact, including co-sleeping. As topical hormone therapies become increasingly common, clinicians must counsel patients on safe application practices and consider exogenous hormone exposure in children presenting with unexplained pubertal development. Switching caregivers from gel to patch formulations can reverse hormone excess in exposed children.</p></sec>]]></description>
<dc:creator><![CDATA[Ng, S. M., Swain, V., Masoud, M., Magee, A., Green, L., Atherton, J., Al-Jubouri, M.]]></dc:creator>
<dc:date>2026-06-01T09:00:21-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2026-330429</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2026-330429</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Problem solving in clinical practice]]></dc:subject>
<dc:title><![CDATA[Peripheral precocious puberty due to inadvertent exposure to topical oestradiol gel and review of the literature]]></dc:title>
<prism:publicationDate>2026-06-01</prism:publicationDate>
<prism:section>PROBLEM SOLVING IN CLINICAL PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2026-330673v1?rss=1">
<title><![CDATA[Noisy breathing and faltering growth in a 2-month-old infant: stertor, not stridor]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2026-330673v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Case presentation</st><p>A term girl was referred at 2 months of age for persistent noisy breathing noted since birth, worse with feeding and in the supine position, with brief apnoeic pauses, occasional perioral cyanosis, poor coordination of mixed breast and formula feeding and faltering growth from the 25th to the 2nd centile. She had no fever, cough or choking, and her birth and neonatal periods were unremarkable. She had previously been managed with nasal saline, nasal decongestant and intranasal steroid, without improvement.</p><p> demonstrates the patient&rsquo;s breathing pattern. No dysmorphic features were noted, and the physical examination was otherwise normal. Oxygen saturation was 100% on room air.</p><p>During the clinic visit, nasal saline irrigation was attempted and marked resistance was immediately noted. After repeated attempts, the infant suffered cardiorespiratory arrest and was successfully resuscitated on site. She was then admitted for observation and work-up.</p></sec><sec id="s2"><st>Test your knowledge</st><p><b>Question 1:</b> What is the most...]]></description>
<dc:creator><![CDATA[Hassoun, M., Malas, A., Khaled, J.]]></dc:creator>
<dc:date>2026-05-29T09:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2026-330673</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2026-330673</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Noisy breathing and faltering growth in a 2-month-old infant: stertor, not stridor]]></dc:title>
<prism:publicationDate>2026-05-29</prism:publicationDate>
<prism:section>EPILOGUE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2026-330424v1?rss=1">
<title><![CDATA[Acute cervical lymphadenitis in a febrile child: when to think beyond infection?]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2026-330424v1?rss=1</link>
<description><![CDATA[<p>A 4-year-old boy presented with fever and unilateral neck swelling, initially treated as bacterial lymphadenitis with intravenous antibiotics. Over the following days, he developed bilateral non-purulent conjunctival injection, palmar erythema, mucosal changes, raised liver transaminases and rising inflammatory markers. The evolving picture led to a diagnosis of Kawasaki disease in the second week of illness.</p><p>Cervical lymphadenitis is a common paediatric presentation, with infective aetiology being the most common. However, inflammatory conditions such as Kawasaki disease and haematological malignancy can present similarly. Among these, &lsquo;Node-first&rsquo; Kawasaki disease, in which cervical lymphadenopathy precedes other features, while a recognised phenotype, is a rarer presentation and therefore a diagnostic pitfall. The similarity to infective lymphadenitis, together with overlapping laboratory and imaging findings, may delay definitive treatment and increase the risk of complications. An acute presentation of cervical lymphadenitis in a febrile child with inadequate or no response despite antibiotics and persistent high inflammatory markers should raise suspicion of possible alternative diagnoses like Kawasaki disease.</p>]]></description>
<dc:creator><![CDATA[Govardhan, C., Prithvi, A., Mappa, P., Roderick, M., Ramanan, A. V., Darma, K.]]></dc:creator>
<dc:date>2026-05-19T09:00:13-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2026-330424</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2026-330424</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Problem solving in clinical practice]]></dc:subject>
<dc:title><![CDATA[Acute cervical lymphadenitis in a febrile child: when to think beyond infection?]]></dc:title>
<prism:publicationDate>2026-05-19</prism:publicationDate>
<prism:section>PROBLEM SOLVING IN CLINICAL PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329848v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Early developmental impairment - an update on diagnostic tests]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329848v1?rss=1</link>
<description><![CDATA[<p>Neurodevelopmental delay is a common clinical presentation to paediatricians. For some children, there may be an immediately recognisable likely cause such as a severe perinatal infection or hypoxia. For others, the cause may not be obvious, leaving open questions of recurrence risk, developmental prognosis, expected medical and mental health needs and optimal management. Although some children will remain undiagnosed, many will have an underlying genetic diagnosis. In this article, we highlight recent advances in the investigation of children with developmental delay with a particular focus on genomics. We advocate performing next-generation sequencing-based tests as a first-line investigation, alongside basic biochemical and metabolic tests, with an aim for greater equity of testing and more rapid diagnosis.</p>]]></description>
<dc:creator><![CDATA[Sarantis, F., Seregni, F., Ratnaike, T., Baker, K., Hogg, S. L., Varma, R., Mitchell, G., Holland, J. A. A.]]></dc:creator>
<dc:date>2026-05-14T09:00:13-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329848</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329848</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Early developmental impairment - an update on diagnostic tests]]></dc:title>
<prism:publicationDate>2026-05-14</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-330118v1?rss=1">
<title><![CDATA[What are bispecific antibodies?]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-330118v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Introduction</st><p>In recent decades therapeutic antibodies have become recognised as an effective form of systemic therapy in the management of many paediatric conditions from Crohn&rsquo;s disease to asthma and cancer.<cross-ref type="bib" refid="R1">1&ndash;3</cross-ref><cross-ref type="bib" refid="R2"></cross-ref><cross-ref type="bib" refid="R3"></cross-ref></p><p>Bispecific antibodies are a growing area in immunotherapy and show promise in advancing treatment of paediatric conditions. Unlike conventional monoclonal antibodies, which recognise and bind a single target, bispecific antibodies are engineered to have two distinct antigen binding domains with specificity to different molecular targets, providing dual specificity and function for therapeutic advantage.<cross-ref type="bib" refid="R4">4</cross-ref> Additionally, through simultaneous action on two pathways or cell types, bispecific antibodies may reduce the need for combination therapies, reducing the complexity of drug dosing and interaction between multiple agents.</p></sec><sec id="s2"><st>How bispecific antibodies work</st><p>Monoclonal antibodies are based on endogenous antibodies and include two identical antigen binding domains, which bind a specific molecular target, and a stem (Fc region) (<cross-ref type="fig"...]]></description>
<dc:creator><![CDATA[Crombie, K., Potluri, S., Apps, J. R.]]></dc:creator>
<dc:date>2026-05-13T09:00:15-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-330118</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-330118</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[What are bispecific antibodies?]]></dc:title>
<prism:publicationDate>2026-05-13</prism:publicationDate>
<prism:section>RESEARCH IN PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-330136v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Is it autism--or something else? A practical clinical guide]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-330136v1?rss=1</link>
<description><![CDATA[<p>Referrals for children presenting with social, communication and behavioural differences have risen sharply in recent years, creating unprecedented demand for autism assessments. Waiting times now frequently exceed 2 years, placing considerable strain on diagnostic services and families. While autism is common, many children presenting with these differences have alternative or co-occurring explanations that require timely recognition and tailored support. This article presents a practical child-centred framework to guide clinicians involved in early assessment or referral decision-making when diagnostic uncertainty exists. It also supports earlier and more equitable access to strengths and needs informed care, regardless of diagnostic outcome.</p>]]></description>
<dc:creator><![CDATA[Stewart, C. E., Keenan, J., Awe, A., Phillips, G., Kroll, L., John-Legere, S., Mathura, N., Sharma, A.]]></dc:creator>
<dc:date>2026-05-11T09:00:26-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-330136</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-330136</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Is it autism--or something else? A practical clinical guide]]></dc:title>
<prism:publicationDate>2026-05-11</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329806v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: The initial assessment of children with a suspected cervical spine injury]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329806v1?rss=1</link>
<description><![CDATA[<p>Cervical spine injury occurs in 1&ndash;2% of paediatric trauma cases. Differences in anatomy, size and injury patterns compared with adult patients can make the assessment of cervical spine injuries in children challenging. This article provides an overview of the approach to be taken when assessing a potential cervical spine injury. It also covers the range of available clinical decision aids to help clinicians diagnose cervical spine injuries while safely avoiding unnecessary radiation as much as possible.</p>]]></description>
<dc:creator><![CDATA[Athanasiou, D., Mitchell, M., Baig, M. A., Hibberd, O., Karageorgos, S.]]></dc:creator>
<dc:date>2026-04-30T09:00:16-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329806</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329806</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: The initial assessment of children with a suspected cervical spine injury]]></dc:title>
<prism:publicationDate>2026-04-30</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2024-328166v1?rss=1">
<title><![CDATA[Adrenal insufficiency: identification and management (NICE guideline NG243)]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2024-328166v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Background</st><p>Adrenal insufficiency (AI) is a disorder characterised by inadequate cortisol production due to dysfunction of the adrenal glands or impairment of the hypothalamic&ndash;pituitary&ndash;adrenal (HPA) axis. It is classified as primary AI, caused by intrinsic adrenal disease, or secondary/tertiary AI, resulting from reduced adrenocorticotropic hormone (ACTH) or corticotropin harmone (CRH) secretion. Because symptoms are often non-specific, diagnosis may be delayed, increasing the risk of adrenal crisis, a potentially life-threatening complication requiring prompt recognition and treatment.<cross-ref type="bib" refid="R1">1</cross-ref> AI is a rare but potentially life-threatening endocrine disorder in children. Early identification and appropriate management, including prevention and prompt treatment of adrenal crisis, are essential to reduce morbidity and mortality. This updated NICE (National Institute for Health and Care Excellence) guideline, published on 28 August 2024, provides comprehensive and practical recommendations across the patient journey from diagnosis to long-term care.</p></sec><sec id="s2"><st>Information about the current guideline</st><p>This guideline<cross-ref type="bib" refid="R1">1</cross-ref> aims to improve the...]]></description>
<dc:creator><![CDATA[Bimb, S., Anand, B.]]></dc:creator>
<dc:date>2026-04-28T09:00:14-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2024-328166</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2024-328166</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Adrenal insufficiency: identification and management (NICE guideline NG243)]]></dc:title>
<prism:publicationDate>2026-04-28</prism:publicationDate>
<prism:section>GUIDELINE REVIEW</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-330107v1?rss=1">
<title><![CDATA[Delandistrogene moxeparvovec: gene therapy for Duchenne muscular dystrophy]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-330107v1?rss=1</link>
<description><![CDATA[<p><textbox id="BWL2"><caption><p>Key learning points</p></caption><p><l type="unord"><li><p>Delandistrogene moxeparvovec is the first gene-replacement therapy for Duchenne muscular dystrophy (DMD) and requires careful patient selection and structured monitoring.</p></li><li><p>Ambulation, defined clinically as the ability to complete the 10-metre walk/run in &lt;30 s, is currently required for treatment eligibility.</p></li><li><p>Acute lung injury remains the most frequent safety concern; enhanced baseline hepatic assessment and early steroid escalation are essential.</p></li><li><p>Younger children may show higher micro-dystrophin expression, but long-term durability is uncertain.</p></li><li><p>Clinical vignettes highlight the value of interpreting trends rather than absolute values during early monitoring.</p></li><li><p>Ongoing pharmacovigilance and real-world data are essential to refine protocols, particularly regarding age at dosing, redosing strategies and combination with other DMD therapies.</p></li></l></p></textbox></p><sec id="s1"><st>Introduction</st><p>Duchenne muscular dystrophy (DMD) is a severe, progressive X-linked disorder caused by pathogenic variants in the <I>DMD</I> gene, resulting in the absence or markedly reduced dystrophin.<cross-ref type="bib" refid="R1">1</cross-ref> Loss of dystrophin destabilises the sarcolemma, leading to progressive muscle damage and weakness.<cross-ref type="bib"...]]></description>
<dc:creator><![CDATA[Mundada, V.]]></dc:creator>
<dc:date>2026-04-24T09:00:17-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-330107</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-330107</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Delandistrogene moxeparvovec: gene therapy for Duchenne muscular dystrophy]]></dc:title>
<prism:publicationDate>2026-04-24</prism:publicationDate>
<prism:section>MEDICINES UPDATE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329421v2?rss=1">
<title><![CDATA['See me Autism: improving the experience and safety of autistic children in the paediatric emergency department]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329421v2?rss=1</link>
<description><![CDATA[<p>Implementation of co-produced training and resources can improve the experience and safety of autistic children in a paediatric emergency department.</p>]]></description>
<dc:creator><![CDATA[Rosen, B. F., Sumaria, K., Miller, C. E., Arbuckle, C., McNamara, T., Callaghan, T., Mazhani, T., Rowley, L., Rivalta-Dallal, A., English, K., Foulkes, E., Julies, P.]]></dc:creator>
<dc:date>2026-04-20T09:00:23-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329421</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329421</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA['See me Autism: improving the experience and safety of autistic children in the paediatric emergency department]]></dc:title>
<prism:publicationDate>2026-04-20</prism:publicationDate>
<prism:section>QUALITY IMPROVEMENT SHORT REPORT</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329226v3?rss=1">
<title><![CDATA[PEARL QIP: Postnatal Early Antibiotic Review for Low-risk babies - transitioning babies home earlier from the postnatal ward using oral antibiotics]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329226v3?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Summary</st><p>We developed a quality improvement project (QIP) switching neonates with culture-negative early onset sepsis (EOS) on the postnatal ward from intravenous to oral antibiotics, reducing length of stay (LOS). We report our findings and QI experience in accordance with SQUIRE (Standards for Quality Improvement Reporting Excellence) 2.0 reporting guidelines.<cross-ref type="bib" refid="R1">1</cross-ref></p></sec><sec id="s2"><st>The problem</st><p>In 2024, 8.3% (330/3993) of babies born at St George&rsquo;s Hospital were treated with intravenous antibiotics for suspected EOS on the postnatal ward. Of these, 39.5% had an elevated C-reactive protein (CRP)&gt;10 mg/L with negative blood cultures. The majority (77%, n=100 annually) were clinically well within 36 hours yet completed 5&ndash;7 days of intravenous antibiotics&mdash;a long-established national practice. Prolonged postnatal admissions have significant cost and workload implications and disrupt early family bonding in an unfamiliar environment.<cross-ref type="bib" refid="R2">2</cross-ref> Recent evidence supports safely switching such babies to oral antibiotics.<cross-ref type="bib" refid="R3">3 4</cross-ref><cross-ref type="bib" refid="R4"></cross-ref></p></sec><sec id="s3"><st>Aims</st><p>We aimed to reduce LOS for...]]></description>
<dc:creator><![CDATA[Scally, N., Leach, H., Thakur, D., Tarakeme, E., Duffy, D.]]></dc:creator>
<dc:date>2026-04-20T09:00:23-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329226</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329226</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[PEARL QIP: Postnatal Early Antibiotic Review for Low-risk babies - transitioning babies home earlier from the postnatal ward using oral antibiotics]]></dc:title>
<prism:publicationDate>2026-04-20</prism:publicationDate>
<prism:section>QUALITY IMPROVEMENT SHORT REPORT</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329875v1?rss=1">
<title><![CDATA[Perinatal palliative care - how to approach antenatal counselling]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329875v1?rss=1</link>
<description><![CDATA[<p>There is a growing recognition that perinatal palliative care is appropriate whenever there is uncertainty about a baby&rsquo;s survival outcome. Many aspects of this care can, and should, be provided by existing perinatal teams, with support from community and specialist services where required. However, delivering perinatal palliative care can be practically, ethically and emotionally challenging for professionals without adequate guidance and training. In this best practice paper, we offer practical guidance for clinicians who may be involved in antenatal counselling when a baby has been diagnosed with a potentially life-limiting condition during pregnancy. We consider how to approach antenatal counselling in the context of prognostic uncertainty, how to support families in being able to treasure their pregnancy, how to remain open to all possibilities, how to develop individualised care plans for families and finally consider how to close the consultation and arrange follow-up. Drawing on the parental experience of one of our authors, we explore how to navigate the concept of hope in perinatal consultations.</p>]]></description>
<dc:creator><![CDATA[Bertaud, S., Bailey, P.-A., Balmforth, S., Brightley, G., English, S., Pearson, A., Williams, K., Association of Paediatric Palliative Medicine (APPM) Perinatal Special Interest Group, Perkins, Hills, Holder, Mott, Smith, Linford, Anderson, Nanda, Ray, Paize, McKibben, Harris]]></dc:creator>
<dc:date>2026-04-15T09:00:13-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329875</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329875</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Perinatal palliative care - how to approach antenatal counselling]]></dc:title>
<prism:publicationDate>2026-04-15</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2024-328290v1?rss=1">
<title><![CDATA[Royal College of Emergency Medicine learning disabilities toolkit]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2024-328290v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Introduction</st><p>This toolkit represents a major shift in attitude in how we approach children with learning disabilities in our emergency departments (EDs). There are over 1.5 million people living with learning disabilities in the UK, making up 2.5% of the UK population.<cross-ref type="bib" refid="R1">1</cross-ref> Given many will have multiple comorbidities, patients with learning disabilities are more likely to attend ED and more frequently. People with learning disabilities face huge barriers to accessing appropriate healthcare and, as a result, are twice as likely to die of avoidable causes.<cross-ref type="bib" refid="R2">2</cross-ref></p><p>The Equality Act of 2010 states that healthcare organisations and professionals have a legal obligation to make reasonable adjustments in order to allow people with disabilities to access the same healthcare as those who do not.<cross-ref type="bib" refid="R3">3</cross-ref></p></sec><sec id="s2"><st>This guideline</st><p>The Learning Disabilities Toolkit was published by the Royal College of Emergency Medicine and Dr Liz Herrieven, Consultant in Emergency Medicine (Sheffield Children&rsquo;s...]]></description>
<dc:creator><![CDATA[Blaney, E., Herrieven, E.-J.]]></dc:creator>
<dc:date>2026-04-14T09:00:12-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2024-328290</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2024-328290</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Royal College of Emergency Medicine learning disabilities toolkit]]></dc:title>
<prism:publicationDate>2026-04-14</prism:publicationDate>
<prism:section>GUIDELINE REVIEW</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-328850v1?rss=1">
<title><![CDATA[Abusive head trauma and the eye in infancy]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-328850v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Background</st><p>Abusive head trauma is a leading cause of traumatic death in infants. Retinal haemorrhages (RHs) can be the earliest and only clinically visible evidence of the aetiology, making the ophthalmic examination a critical component in triggering child protection pathways.<cross-ref type="bib" refid="R1">1</cross-ref> Diagnostic difficulties arise from potential overlap with non-abusive conditions such as coagulopathies, birth trauma or artefacts from resuscitation, which can produce RHs that sometimes resemble those seen in abuse.<cross-ref type="bib" refid="R2">2 3</cross-ref><cross-ref type="bib" refid="R3"></cross-ref> Considering this, ophthalmological examination must be used as part of a detailed and comprehensive examination and set of investigations as per the child protection companion.<cross-ref type="bib" refid="R4">4</cross-ref> This updated guideline reflects the need for robust, standardised documentation of ophthalmic findings that can withstand scrutiny in medico-legal settings.</p><sec id="s1-1"><st>Current and previous guideline summary</st><p>The current guideline was commissioned and published in 2024 by the Royal College of Ophthalmologists (RCOphth), with endorsement of the Royal College of...]]></description>
<dc:creator><![CDATA[Keenan, M., Dalrymple, R., Brady, C., Millar, E.]]></dc:creator>
<dc:date>2026-04-09T09:00:14-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-328850</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-328850</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Abusive head trauma and the eye in infancy]]></dc:title>
<prism:publicationDate>2026-04-09</prism:publicationDate>
<prism:section>GUIDELINE REVIEW</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-330235v1?rss=1">
<title><![CDATA[Spontaneous auto-amputation of a juvenile polyp in a 5-year-old with haematochezia]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-330235v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Case presentation</st><p>A boy aged 5 years old presented with a 6-week history of intermittent painless rectal bleeding. Clinical examination was unremarkable, and initial investigations including full blood count, faecal calprotectin and Meckel&rsquo;s scan were normal. The parents discovered a spontaneously expelled fleshy mass in his stool (<cross-ref type="fig" refid="F1">figure 1</cross-ref>), prompting urgent gastroenterology referral. Family history was significant for colonic polyps and ulcerative colitis, though no genetic mutation had been established in relatives.</p><p>Colonoscopy revealed a large 2 cm pedunculated, cauliflower-shaped polyp in the caecum (<cross-ref type="fig" refid="F2">figure 2</cross-ref>), alongside six additional polyps throughout the colon (seven polyps total). Four polyps were successfully resected endoscopically. Histology confirmed all lesions as benign juvenile polyps without dysplasia. The auto-amputated polyp demonstrated typical features of torsion at the stalk. The patient has been clinically diagnosed with juvenile polyposis syndrome based on the presence of seven juvenile polyps.<cross-ref type="bib" refid="R1">1 2</cross-ref><cross-ref type="bib" refid="R2"></cross-ref> Six monthly...]]></description>
<dc:creator><![CDATA[Abu Fayyad, M., Derry, C.]]></dc:creator>
<dc:date>2026-04-09T09:00:14-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-330235</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-330235</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Spontaneous auto-amputation of a juvenile polyp in a 5-year-old with haematochezia]]></dc:title>
<prism:publicationDate>2026-04-09</prism:publicationDate>
<prism:section>EPILOGUE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329864v1?rss=1">
<title><![CDATA[Developmental and clinical perspectives guiding neurodevelopmental follow-up of high-risk newborns]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329864v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Introduction</st><p>This article is the first in a series on neurodevelopmental follow-up of infants born preterm or those born at term but admitted to neonatal intensive care. The discussions in this series also apply to infants and children with developmental or early acquired brain injuries or those with congenital disorders, such as congenital cardiac disorders, that increase their risk of neurodevelopmental problems. The focus is exclusively on central nervous system pathologies; peripheral nervous system and neuromuscular disorders are excluded.</p><p>This first article introduces key concepts of typical and atypical development, discusses what can go wrong in development (&lsquo;atypical development&rsquo;), who is at particular risk of atypical development, and outlines the importance of structured neurodevelopmental follow-up (<cross-ref type="box" refid="B1">box 1</cross-ref>).</p><p><textbox id="B1"><no>Box 1</no><caption><p>Key messages</p></caption><p><l type="unord"><li><p>The developing brain is vulnerable to adversities; however, heightened neuroplasticity offers opportunities for intervention.</p></li><li><p>The timing of brain injury or exposure to adverse environmental conditions determines the clinical phenotype of...]]></description>
<dc:creator><![CDATA[Fernandes, M., Hadders-Algra, M., Edmonds, C. J., Vollmer, B.]]></dc:creator>
<dc:date>2026-04-09T09:00:13-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329864</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329864</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Developmental and clinical perspectives guiding neurodevelopmental follow-up of high-risk newborns]]></dc:title>
<prism:publicationDate>2026-04-09</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-330172v1?rss=1">
<title><![CDATA[Integrating neighbourhood care for children]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-330172v1?rss=1</link>
<description><![CDATA[<p>&lsquo;While health and illness may involve biological agents and processes, they are inseparable from the social settings in which people live. Ultimately, it is these which influence the challenges people encounter in daily life and their capacity to manage them&rsquo;.<cross-ref type="bib" refid="R1">1</cross-ref></p><p>Most readers will know this, but what type of care can best meet these challenges? &lsquo;Integrating care is not just an improvement but a necessity&rsquo;, as the authors of the first paper in the series published in this edition state. The three articles in this series describe the rationale for integrated neighbourhood care for children, its value, describing several detailed case studies and presenting evidence of effectiveness, together with some of the practical steps required for implementation. These pieces help towards providing a compelling case for its wider adoption as a preferred paradigm of care.</p><p>Families are presenting, in increasing numbers, to their general practitioners (GPs) with a wide range...]]></description>
<dc:creator><![CDATA[Blair, M.]]></dc:creator>
<dc:date>2026-04-02T09:00:19-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-330172</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-330172</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Integrating neighbourhood care for children]]></dc:title>
<prism:publicationDate>2026-04-02</prism:publicationDate>
<prism:section>EDITORIAL</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329841v1?rss=1">
<title><![CDATA[Standard concentration infusions in neonatal care: a critical review of the literature and guidance for implementation in practice]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329841v1?rss=1</link>
<description><![CDATA[<p><textbox id="BX1"><caption><p>Key messages</p></caption><p><l type="unord"><li><p>Development of neonatal standard concentration infusions was recommended to improve neonatal drug safety and service efficiency in the National Health Service England Getting It Right First Time Neonatology national specialty report.</p></li><li><p>&lsquo;Smart pumps&rsquo; and electronic prescribing can support this change; however, these are not available to everyone and require significant time and resource to implement.</p></li><li><p>The major opportunities for error with standard concentration infusions are in calculating the rate of infusion with dose changes. This is relatively simple to overcome, and we provide a simple aide memoire for practitioners to use.</p></li></l></p></textbox></p><sec id="s1"><st>Introduction</st><p>There is a national debate about how we transition our neonatal units to standard concentration infusions (SCIs) to improve safety and efficiency. This paper sets out the background on how the current frameworks of neonatal SCIs were developed, and how safe prescribing can be supported in practice without using complex technologies.</p><sec id="s1-1"><st>Current practice</st><p>Traditionally, intravenous infusions for neonates are...]]></description>
<dc:creator><![CDATA[Hibberd, S., Hinton, R., Gaze, S., Gooding, N., Adams, E., Sutherland, A.]]></dc:creator>
<dc:date>2026-03-23T09:00:18-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329841</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329841</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Standard concentration infusions in neonatal care: a critical review of the literature and guidance for implementation in practice]]></dc:title>
<prism:publicationDate>2026-03-23</prism:publicationDate>
<prism:section>MEDICINES UPDATE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329397v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Diagnosing and managing protracted bacterial bronchitis in children and young people]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329397v1?rss=1</link>
<description><![CDATA[<p>Protracted bacterial bronchitis (PBB) is a frequent yet often underdiagnosed cause of chronic wet cough in young children, commonly mistaken for asthma or other respiratory conditions. It is characterised by a cough lasting more than 4 weeks that typically improves with an extended 4&ndash;6 week course of appropriate antibiotics, guided by allergy status and microbiological culture results where available, with co-amoxiclav being the usual first choice. PBB can progress to bronchiectasis if left untreated, with significant long-term implications for lung health. Early recognition is therefore crucial. This article outlines a practical approach to diagnosing PBB, emphasising the need to exclude other causes of persistent cough, obtain appropriate imaging and microbiological samples and consider specialist referral for non-responders to prolonged antibiotics or in recurrent cases. By promptly identifying and treating PBB, clinicians can reduce the risk of disease progression and improve long-term outcomes for paediatric patients.</p>]]></description>
<dc:creator><![CDATA[McGough, A., Brodlie, M., Gray, S. J., Legg, J. P.]]></dc:creator>
<dc:date>2026-03-18T09:00:14-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329397</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329397</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Diagnosing and managing protracted bacterial bronchitis in children and young people]]></dc:title>
<prism:publicationDate>2026-03-18</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329863v1?rss=1">
<title><![CDATA[Moving parts: toddler presenting with new movement disorder]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329863v1?rss=1</link>
<description><![CDATA[<p>A 20-month-old boy was brought to hospital after suddenly developing uncoordinated right-sided upper and lower limb movements, with loss of balance while playing at home. He was afebrile and otherwise well apart from a mild cough, with no history of head trauma. There was no neurological family history, and no significant medical history. Neurological examination demonstrated facial symmetry, with rhythmic right-sided posterior arm movements and kicking of the right leg with normal reflexes bilaterally; however, he was still able to produce purposeful movements. The examination findings were consistent with hemiballismus hemichorea due to their unilateral nature.<cross-ref type="bib" refid="R1">1</cross-ref> Baseline observations were normal for his age and are shown below:</p><p><l type="unord"><li><p>Blood pressure: 99/50 mm Hg.</p></li><li><p>Blood glucose: 5.8 mmol/L.</p></li><li><p>Respiratory rate: 32 breaths per minute.</p></li><li><p>Saturations: 98% in air.</p></li><li><p>Heart rate: 130 beats per minute.</p></li><li><p>Temperature: 37.1&deg;C.</p></li></l></p><p>An urgent awake encephalogram and CT of the head demonstrated no abnormalities. The following day, he underwent an MRI of...]]></description>
<dc:creator><![CDATA[Riches, S. J., Edwards, M., Jacoby, J., Tighe, M. P.]]></dc:creator>
<dc:date>2026-03-16T09:00:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329863</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329863</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Moving parts: toddler presenting with new movement disorder]]></dc:title>
<prism:publicationDate>2026-03-16</prism:publicationDate>
<prism:section>EPILOGUE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329134v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Integrated child health: Part 3 - How to design and implement locally]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329134v1?rss=1</link>
<description><![CDATA[<p>Based on a review of global exemplars and local UK experiences, in the third of our series, this article provides a practical framework for designing and implementing integrated child health services at a local level. It responds to the national vision of &lsquo;Neighbourhood Health&rsquo; by distilling key design principles from successful models. The proposed framework is built on five core pillars: establishing a co-produced, person-centred vision that addresses social determinants; nurturing strong multidisciplinary relationships and trust; fostering a supportive culture that embeds continuous improvement and learning; effectively harnessing shared digital tools and data; and implementing the right incentives and outcome measures to gauge impact and drive change. This final paper of the series provides an actionable &lsquo;how-to&rsquo; guide for the core components defined in part 2, in order to realise the vision for integrated care set out in part 1.</p>]]></description>
<dc:creator><![CDATA[Klaber, R. E., Tailor, D., Watson, M.]]></dc:creator>
<dc:date>2026-03-11T09:00:21-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329134</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329134</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Integrated child health: Part 3 - How to design and implement locally]]></dc:title>
<prism:publicationDate>2026-03-11</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329132v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Integrated child health: Part 1 - Why integrated care matters]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329132v1?rss=1</link>
<description><![CDATA[<p>Integrated care for children and young people in England represents a transformative shift towards holistic, person-centred health services tailored to the needs of local communities. In this first part of a series of three, we describe what we mean by integrated care, and why it is needed now, setting the context for the subsequent parts that detail integrated care&rsquo;s core components and practical implementation.</p><p>Integrated care addresses multidimensional needs&mdash;physical health, mental wellbeing, education and social development&mdash;while reducing fragmentation and inefficiency. This approach enables early intervention and improves health equity. Key benefits include streamlined access for families, reduced hospital admissions and better outcomes for vulnerable groups, such as children with complex conditions or those facing social and economic challenges.</p><p>The evolution of UK child health policy, from the 1959 Platt Report to the 2025 National Health Service 10-Year Health Plan for England, underscores the growing emphasis on multidisciplinary, community-based models. By adopting a whole-population approach&mdash;segmenting children by health and social needs rather than rigid pathways&mdash;integrated care enables every child to be supported and cared for.</p><p>Ultimately, integrated care is not just an improvement but a necessity, addressing rising demand, workforce pressures and persistent inequities. It fosters proactive, collaborative systems that prioritise children&rsquo;s wellbeing, offering a sustainable future for child health and care services in England.</p>]]></description>
<dc:creator><![CDATA[Holden, B., Adnan, S., Watson, M.]]></dc:creator>
<dc:date>2026-03-11T09:00:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329132</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329132</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Integrated child health: Part 1 - Why integrated care matters]]></dc:title>
<prism:publicationDate>2026-03-11</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329133v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Integrated child health: Part 2 - Clinical practice]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329133v1?rss=1</link>
<description><![CDATA[<p>This article explores the core components of effective integrated care for children and young people, moving beyond theory to present practical implementation. It outlines five essential elements: proactive case identification through risk stratification; multidisciplinary case discussion for holistic care planning; direct, joint clinical care in community settings; continuous professional knowledge sharing; and active engagement of families and communities in co-producing services. These components work synergistically to shift care from a reactive to a preventative model, and to shift care from the hospital to the community. Supported by real-world case studies, the analysis demonstrates how this approach provides holistic, equitable and coordinated care that is tailored to the evolving needs of children and their families. As the second paper in a three-part series, this article bridges the rationale for integrated care established in Part 1, with the practical implementation framework provided in Part 3.</p>]]></description>
<dc:creator><![CDATA[Moore, Y., McLaughlin, N., Watson, M.]]></dc:creator>
<dc:date>2026-03-11T09:00:20-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329133</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329133</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Integrated child health: Part 2 - Clinical practice]]></dc:title>
<prism:publicationDate>2026-03-11</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329549v1?rss=1">
<title><![CDATA[Improving the provision of neonatal education for junior paediatric resident doctors]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329549v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Summary</st><p>We present a quality improvement project to improve junior paediatric resident doctors&rsquo; confidence in neonatology in preparation for working on the Tier 2 rota, by implementing a neonatal study day into a regional paediatric education programme.</p></sec><sec id="s2"><st>The problem</st><p>In 2022&ndash;2023, 4.3% of 375 foundation posts contained a neonatal rotation; therefore, many paediatric resident doctors enter their first neonatal rotation without previous experience.<cross-ref type="bib" refid="R1">1</cross-ref> The Royal College of Paediatrics and Child Health (RCPCH) has changed the shape of training by reducing paediatric residency from 8 to 7 years and entering resident doctors onto the Tier 2 rota at &lsquo;ST3b&rsquo;, 6 months earlier than previously.<cross-ref type="bib" refid="R2">2</cross-ref> On the RCPCH Progress+curriculum, 6 months of tertiary neonatology within Level 1 training is no longer compulsory and intubation is no longer a mandatory directly observed procedure.<cross-ref type="bib" refid="R2">2</cross-ref></p></sec><sec id="s3"><st>Aims</st><p>To improve junior paediatric resident doctors&rsquo; confidence in neonatal skills through a 1-day face-to-face course.</p></sec><sec id="s4"><st>Making a...]]></description>
<dc:creator><![CDATA[Aghababaie, A., Downes, A., Shetty, S.]]></dc:creator>
<dc:date>2026-03-10T09:00:13-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329549</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329549</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Improving the provision of neonatal education for junior paediatric resident doctors]]></dc:title>
<prism:publicationDate>2026-03-10</prism:publicationDate>
<prism:section>QUALITY IMPROVEMENT SHORT REPORT</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329192v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Paediatric facial fractures]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329192v1?rss=1</link>
<description><![CDATA[<p>Facial trauma is commonly encountered in the paediatric population, with its prevalence and severity influenced by age, the unique characteristics of developing facial anatomy and injury mechanism. A thorough yet targeted history, along with a detailed clinical examination during the initial evaluation in the emergency department (ED), is essential for effective management. This article provides an overview of facial fractures; mandibular, nasal, orbital, zygomatic and maxillary&mdash;with a specific focus on their assessment and management in the ED setting.</p>]]></description>
<dc:creator><![CDATA[Flaherty, E., Patel, S., Evans, J., Micic, T., Murray, D., Fox, C.]]></dc:creator>
<dc:date>2026-03-03T09:00:15-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329192</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329192</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Paediatric facial fractures]]></dc:title>
<prism:publicationDate>2026-03-03</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-328955v1?rss=1">
<title><![CDATA[Use of ileal bile acid transporter inhibitors in children with genetic familial cholestasis and Alagille syndrome: the why, when and how]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-328955v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Background</st><p>Pruritus is a common distressing symptom in Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille syndrome. Severe itching often results in bleeding excoriations, sleep deprivation, poor school performance, impaired mood and social behaviour, resulting in poor quality of life for both the child and their family. For decades, management has relied on general supportive measures and off-label pharmacotherapy, with limited success (<cross-ref type="box" refid="B1">box 1</cross-ref>). Surgical biliary diversion aimed at reducing the serum bile acid pool has been effective in some, while liver transplantation is reserved for those with progressive liver disease and refractory pruritus. Following Medicines and Healthcare products Regulatory Agency (MHRA) approval in the UK, IBAT inhibitors (IBATi), Odevixibat and Maralixibat, are now available in clinical practice for use in children with PFIC and Alagille syndrome. The National Institute for Health and Care Excellence provides recommendations for Odevixibat under Highly Specialised Technologies Guidance, while Maralixibat is under active...]]></description>
<dc:creator><![CDATA[Mahesh, S., Kelgeri, C.]]></dc:creator>
<dc:date>2026-02-24T09:00:16-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-328955</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-328955</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Use of ileal bile acid transporter inhibitors in children with genetic familial cholestasis and Alagille syndrome: the why, when and how]]></dc:title>
<prism:publicationDate>2026-02-24</prism:publicationDate>
<prism:section>MEDICINES UPDATE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329811v1?rss=1">
<title><![CDATA[Understanding doping and anti-doping: a guide for the general paediatrician]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329811v1?rss=1</link>
<description><![CDATA[<p>The use of image and performance enhancing drugs (IPEDs) and the consumption of nutritional supplements are rising in young people, yet most paediatricians have limited experience in this emerging area of practice. This article aims to increase awareness of the scale of the issue; to suggest when IPED use might be suspected; and how to investigate and manage it practically and holistically. It stresses the risks of online nutritional supplements, which are frequently contaminated with potentially harmful substances and increasingly easy to purchase online on social media. It summarises what is known about the risks and adverse effects, particularly cardiac, endocrine and psychological complications, some of which can be irreversible. The article then highlights the risk that some young people involved in sport may be underdosing themselves with necessary medication out of concerns that they could fail drug testing. It also discusses how to prescribe for young competing athletes; how to check which medications are banned for that athlete; and how to prescribe medication which is clinically indicated but on the prohibited list.</p>]]></description>
<dc:creator><![CDATA[Cohen, M. B., Jenner, R.]]></dc:creator>
<dc:date>2026-02-17T09:00:15-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329811</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329811</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Understanding doping and anti-doping: a guide for the general paediatrician]]></dc:title>
<prism:publicationDate>2026-02-17</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329173v1?rss=1">
<title><![CDATA[Suspected nitrous oxide toxicity in emergency departments: Royal College of Emergency Medicine best practice guideline review]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329173v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Background</st><p>Nitrous oxide (N<SUB>2</SUB>O) or more commonly known as &lsquo;laughing gas&rsquo; is a short-acting anaesthetic agent. It has been used both in medicine and recreationally for over 200 years for its analgesic and antianxiety properties. In the year ending March 2020, use in the last 12 months was reported by 2.4% of adults aged 16&ndash;59, and 8.7% of adults aged 16&ndash;24.</p><p>There is inconsistent national data regarding N<SUB>2</SUB>O use and reported deaths. However, more recent anecdotal evidence suggests an increase in hospital admissions related to N<SUB>2</SUB>O chronic toxicity, although mortality rates are low.</p></sec><sec id="s2"><st>Information about the current guideline</st><p>A guideline on suspected N<SUB>2</SUB>O toxicity in emergency departments (EDs) was produced by the Royal College of Emergency Medicine (RCEM) in April 2023 to promote emergency medicine clinicians to consider N<SUB>2</SUB>O toxicity as a differential and how to appropriately investigate this early to support diagnosis. No previous guidelines existed specifically for suspected N<SUB>2</SUB>O toxicity in...]]></description>
<dc:creator><![CDATA[Quereshi, A., Tall, R.]]></dc:creator>
<dc:date>2026-02-13T21:05:10-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329173</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329173</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Suspected nitrous oxide toxicity in emergency departments: Royal College of Emergency Medicine best practice guideline review]]></dc:title>
<prism:publicationDate>2026-02-13</prism:publicationDate>
<prism:section>GUIDELINE REVIEW</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329120v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Managing behaviours that challenge in children and young people with intellectual disability]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329120v1?rss=1</link>
<description><![CDATA[<p>Children and young people who present with behaviour that challenges on a background of intellectual disability commonly present to paediatricians for support. This paper gives a structure to explore the possible biological, psychosocial and environmental underlying problems and suggests ways to assess and address these.</p>]]></description>
<dc:creator><![CDATA[Prince, E., Laughlin, R., Swanepoel, A.]]></dc:creator>
<dc:date>2026-02-05T09:00:13-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329120</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329120</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Managing behaviours that challenge in children and young people with intellectual disability]]></dc:title>
<prism:publicationDate>2026-02-05</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329352v1?rss=1">
<title><![CDATA[Joint British Association for Sexual Health and HIV and Royal College of Obstetricians and Gynaecologists national UK guideline for the management of herpes simplex virus in pregnancy and the neonate (2024 update): a review of neonatal aspects of guidance]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329352v1?rss=1</link>
<description><![CDATA[<p>Herpes simplex virus (HSV) in pregnancy is important for all those treating neonates across neonatal, maternity and paediatric settings. There is a risk of neonatal transmission in the genital tract or postnatally, and HSV has the potential for serious sequelae in neonates. HSV mortality is estimated at 29% for disseminated disease, 4% for central nervous system (CNS) disease and 0% for isolated skin, eye and mouth (SEM) disease. Among survivors, 17% of those with disseminated disease, 31% of those with CNS disease and 2% of those with SEM are estimated to have neurodevelopmental complications.<cross-ref type="bib" refid="R1">1</cross-ref></p><p>This 2024 collaborative guideline between the British Association for Sexual Health and HIV (BASHH) and the Royal College of Obstetricians and Gynaecologists (RCOG) provides new recommendations on the management of genital HSV in pregnant people, their partners/contacts and neonates.<cross-ref type="bib" refid="R1">1</cross-ref> This review summarises neonatal management recommendations.</p><sec id="s1"><st>Previous and comparable guidelines</st><p>This guideline supersedes &lsquo;Management of...]]></description>
<dc:creator><![CDATA[Tolosana-Serrano, P., Barnden, J., Premaratne, M., Wooding, E. L.]]></dc:creator>
<dc:date>2026-01-28T09:00:14-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329352</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329352</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Joint British Association for Sexual Health and HIV and Royal College of Obstetricians and Gynaecologists national UK guideline for the management of herpes simplex virus in pregnancy and the neonate (2024 update): a review of neonatal aspects of guidance]]></dc:title>
<prism:publicationDate>2026-01-28</prism:publicationDate>
<prism:section>GUIDELINE REVIEW</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329360v1?rss=1">
<title><![CDATA[Practical strategies to maximise medical simulation learning with minimal resources]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329360v1?rss=1</link>
<description><![CDATA[<p>Simulation-based education is a powerful tool for clinical skills development, but its implementation is often hindered by resource constraints, time limitations and institutional barriers. Effective simulation can occur in almost any setting, regardless of technology or budget; the key drivers of learning are not high-fidelity equipment and dedicated simulation centres, but rather carefully selected learning objectives, engaged faculty and motivated participants.</p><p>Effective simulation begins with a targeted needs assessment and the development of achievable learning outcomes. New educators should avoid &lsquo;the fidelity trap&rsquo; where an over-reliance on expensive or complex simulation tools and technology counterintuitively reduces educational value, and instead focus on simplified low-cost scenarios with high-impact patient outcomes. Scenario design can be enhanced by adapting real-life cases, using free online resources and cautiously incorporating generative artificial intelligence for content creation. Quality and safety must be prioritised through rigorous review, ensuring relevance to local practices, whichever method of scenario generation is taken.</p><p>Task trainers, simulated monitors and audiovisual cues can all be created using cheap, accessible tools which can immerse participants in the scenario without breaking departmental budgets.</p><p>This article aims to empower new simulation educators to deliver impactful, accessible simulation through careful planning and creative resource development.</p>]]></description>
<dc:creator><![CDATA[Talbot, J., Sharp, L., Barrett, D., Wallace, J., Best, H., Volkman, T.]]></dc:creator>
<dc:date>2026-01-28T09:00:14-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329360</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329360</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Learning and teaching]]></dc:subject>
<dc:title><![CDATA[Practical strategies to maximise medical simulation learning with minimal resources]]></dc:title>
<prism:publicationDate>2026-01-28</prism:publicationDate>
<prism:section>LEARNING AND TEACHING</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-328557v1?rss=1">
<title><![CDATA[Symptom management: how can specialist paediatric palliative care teams help?]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-328557v1?rss=1</link>
<description><![CDATA[<p><textbox id="BWL4"><caption><p>Key points</p></caption><p><l type="unord"><li><p>While pain is relatively common in children who are life-limited or life-threatened, they may present with a wide range of symptoms including agitation/distress, dystonia, sleep problems, feed-related problems, gastrointestinal symptoms and breathlessness.</p></li><li><p>Pharmacological treatment is only one aspect of palliative care symptom management. Writing a tailored symptom management plan with non-pharmacological approaches included may help give parents or young people agency and optimise symptom control.</p></li><li><p>Consider the best route of administration for medications for the child and adapt with changing conditions.</p></li></l></p></textbox></p><sec id="s1"><st>Background</st><p>With a rising number of children living with life-limiting conditions in the UK,<cross-ref type="bib" refid="R1">1</cross-ref> paediatricians are managing increasing medical complexity in ward and outpatient environments. Paediatricians should be supported in the identification of those with life-limiting or life-threatened conditions who may benefit from specialist palliative care and early holistic approaches to care, to focus on quality of life alongside active treatment.<cross-ref type="bib" refid="R2">2</cross-ref> Referral to specialist paediatric...]]></description>
<dc:creator><![CDATA[Holland, C., Nohavicka, L., Harrop, E. J.]]></dc:creator>
<dc:date>2026-01-23T09:00:17-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-328557</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-328557</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Symptom management: how can specialist paediatric palliative care teams help?]]></dc:title>
<prism:publicationDate>2026-01-23</prism:publicationDate>
<prism:section>MEDICINES UPDATE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329423v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: Fluid management in children with cirrhosis]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329423v1?rss=1</link>
<description><![CDATA[<p>Cirrhosis is a histological description of the liver characterised by widespread disruption of normal liver structure, which becomes distorted with regenerative nodules surrounded by diffuse fibrosis. Patients with cirrhosis are characterised by a unique physiological state with haemodynamic derangements of systemic vasodilation and functional intravascular hypovolaemia. Liver transplantation can be life-saving in children with cirrhosis but their fluid and electrolyte disequilibrium can be difficult to manage. A close, shared-care arrangement between the local hospital and transplant centre is essential in today&rsquo;s climate where there is an ever-increasing number of children on the waiting list. This article aims to provide a concise and pragmatic guide to fluid management in children with cirrhosis.</p>]]></description>
<dc:creator><![CDATA[Hegarty, R., Dhawan, A.]]></dc:creator>
<dc:date>2026-01-16T09:00:15-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329423</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329423</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: Fluid management in children with cirrhosis]]></dc:title>
<prism:publicationDate>2026-01-16</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329469v1?rss=1">
<title><![CDATA[Management of patients with suspected but unidentified poisoning in the emergency department (Royal College of Emergency Medicine Best Practice Guideline 2025)]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329469v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Background</st><p>Poisoning can present with a variety of symptoms and should be considered as a cause in perplexing presentations. In general, deliberate self-harm with known substances is commoner than exposure to an unknown substance. However, children are at higher risk of accidental ingestion of inadequately secured medications or household products. They are also at increased risk of transdermal and respiratory absorption of toxins due to their different anatomy (higher body surface area to volume ratio) and physiology (increased respiratory rate).</p></sec><sec id="s2"><st>About the current guideline</st><p>This is a Royal College of Emergency Medicine (RCEM) Best Practice Guideline published with the National Poisons Information Service (NPIS) in April 2025. It outlines a general approach for assessing and treating all patients suspected of being poisoned by an unknown substance.</p><sec id="s2-1"><st>Previous guideline(s)</st><p>This 2025 guideline should be used alongside TOXBASE and the NPIS which provide up to date guidelines which are poison specific. Advice on antidote...]]></description>
<dc:creator><![CDATA[Reynolds, S., Ramsden, N., Richens, N.]]></dc:creator>
<dc:date>2026-01-06T09:00:22-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329469</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329469</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Guideline review]]></dc:subject>
<dc:title><![CDATA[Management of patients with suspected but unidentified poisoning in the emergency department (Royal College of Emergency Medicine Best Practice Guideline 2025)]]></dc:title>
<prism:publicationDate>2026-01-06</prism:publicationDate>
<prism:section>GUIDELINE REVIEW</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329142v1?rss=1">
<title><![CDATA[Sepsis, or something more?]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329142v1?rss=1</link>
<description><![CDATA[<p>A 6-year-old boy presented to our emergency department with sepsis; however, sometimes things are not as simple as they initially seem.</p>]]></description>
<dc:creator><![CDATA[Sumner, J. D., Karunasekara, C., Hindocha, S., Ali, A.]]></dc:creator>
<dc:date>2025-11-27T03:40:39-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329142</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329142</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Problem solving in clinical practice]]></dc:subject>
<dc:title><![CDATA[Sepsis, or something more?]]></dc:title>
<prism:publicationDate>2025-11-27</prism:publicationDate>
<prism:section>PROBLEM SOLVING IN CLINICAL PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2024-328251v1?rss=1">
<title><![CDATA[Improving participation in research: embedding critical thinking in clinical practice]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2024-328251v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Background</st><p>It is a common perception that, in parallel with clinical training pressures and requirements, creating a window for undertaking research outside of a formal academic appointment is unachievable.</p><p>In this piece which, though primarily aimed at clinicians, is generic to all healthcare staff, I would like to try to demonstrate that research can be and should be accessible to all.</p></sec><sec id="s2"><st>What does research mean? What are the prerequisites?</st><p>A reasonable working definition is that research is &lsquo;the means of asking a relevant question and having the tools to answer it.&rsquo; The prerequisite is the final common pathway: improving care for children.</p><p>No one would dispute that training one&rsquo;s mind to be able to articulate relevant questions and finding ways of answering them makes a paediatrician, or anyone involved in providing care for children, better equipped and more rounded as a doctor.</p><p>None of this needs to require a doctoral degree, training scheme or...]]></description>
<dc:creator><![CDATA[Brown, N.]]></dc:creator>
<dc:date>2025-11-24T09:00:13-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2024-328251</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2024-328251</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Improving participation in research: embedding critical thinking in clinical practice]]></dc:title>
<prism:publicationDate>2025-11-24</prism:publicationDate>
<prism:section>RESEARCH IN PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329737v1?rss=1">
<title><![CDATA[Migratory annular eruptions in a febrile neonate: when lesions tell a story]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329737v1?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Case presentation</st><p>A 26-day-old male neonate presented with a 3-day history of low-grade fever (maximum 38.5&deg;C), increased irritability, decreased oral intake and skin eruptions. The patient was born at 39 weeks&rsquo; gestation following an uncomplicated pregnancy and spontaneous vaginal delivery, weighing 3.7 kg. The neonatal period was unremarkable until presentation. On examination, vital signs included temperature of 38.2&deg;C, heart rate of 145 beats per minute, respiratory rate of 42 breaths per minute and oxygen saturation of 98% on room air. The infant appeared alert but irritable. Cardiovascular, respiratory, abdominal and neurological examinations were within normal limits. The striking skin findings consisted of multiple well-demarcated, annular erythematous lesions with central clearing distributed over bilateral lower extremities (<cross-ref type="fig" refid="F1">figure 1</cross-ref>). Individual lesions demonstrated mildly raised erythematous borders with central dusky discolouration, displaying a polycyclic configuration without mucosal involvement or vesicle formation. Parents also reported lesional migration and morphological changes over approximately...]]></description>
<dc:creator><![CDATA[Hassoun, M., Houjairy, A., Malas, A.]]></dc:creator>
<dc:date>2025-11-15T09:00:16-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329737</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329737</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Migratory annular eruptions in a febrile neonate: when lesions tell a story]]></dc:title>
<prism:publicationDate>2025-11-15</prism:publicationDate>
<prism:section>EPILOGUE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329503v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: A structured approach to management of sudden unexpected postnatal collapse]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329503v1?rss=1</link>
<description><![CDATA[<p>Managing a neonate presenting with sudden unexpected postnatal collapse requires the skillset of multiple specialities working together in a stressful situation. Recognition of abnormal neonatal physiology and rapid resuscitation is required for stabilisation. This article aims to provide clinicians with an overview of the key differentials and rationale for initial stabilisation and management strategies. It is relevant to paediatricians as well as clinicians in emergency medicine, anaesthesia and adult critical care who will form the paediatric resuscitation team.</p>]]></description>
<dc:creator><![CDATA[Bradford, J., Weeks, C. L., Baldock, A. J., Griksaitis, M. J.]]></dc:creator>
<dc:date>2025-11-09T09:00:18-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329503</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329503</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: A structured approach to management of sudden unexpected postnatal collapse]]></dc:title>
<prism:publicationDate>2025-11-09</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2025-329478v1?rss=1">
<title><![CDATA[Fifteen-minute consultation: A neonate with suspected critical congenital heart disease]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2025-329478v1?rss=1</link>
<description><![CDATA[<p>A focused, practical guide for general paediatricians and resident doctors managing neonates with suspected critical congenital heart disease (CHD), a spectrum of life-threatening cardiac defects requiring intervention. Through detailed case examples, we simulate real-world scenarios that highlight the diagnostic challenges and importance of early recognition. The article reviews essential clinical signs&mdash;including differential preductal and postductal oxygen saturations, persistent cyanosis unresponsive to oxygen, poor perfusion and weak femoral pulses&mdash;that should raise suspicion for critical CHD. It outlines a stepwise approach to initial management, encompassing immediate stabilisation with cautious fluid administration, and the early use of prostaglandin E1 infusions to maintain and increase ductal patency in duct-dependent lesions. Guidance is provided on prostaglandin, escalation, monitoring for side effects and the need for early discussion with tertiary cardiac centres. The article also addresses the careful titration of oxygen therapy to avoid potential risks unique to certain cardiac physiologies. Emphasis is placed on the limitations of prenatal screening programmes and the need for vigilance in postnatal care. Supplementary quiz questions reinforce key learning objectives and ensure knowledge retention. In summary, this article serves as an educational resource for prompt recognition, stabilisation and referral of neonates with critical CHD.</p>]]></description>
<dc:creator><![CDATA[Burgess, X., Spinty, J., Elnazir, P., Hawcutt, D., Capobianco, L., Khan, S.]]></dc:creator>
<dc:date>2025-11-06T23:37:18-08:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2025-329478</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2025-329478</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:subject><![CDATA[Best practice and Fifteen Minute Consultations]]></dc:subject>
<dc:title><![CDATA[Fifteen-minute consultation: A neonate with suspected critical congenital heart disease]]></dc:title>
<prism:publicationDate>2025-11-06</prism:publicationDate>
<prism:section>BEST PRACTICE</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2024-328409v2?rss=1">
<title><![CDATA[My Voice Matters: improving the quality and quantity of the voice of the child captured in child protection medical assessments by introducing a visual communication toolkit]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2024-328409v2?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Summary</st><p>Introduction of a visual communication toolkit into child protection medical assessments (CPMAs) to ensure that verbal communication is never a barrier to being heard&mdash;a multi-agency quality improvement project co-designed with children and young people (CYP).</p></sec><sec id="s2"><st>The problem</st><p>The importance of the voice of the child in safeguarding procedures is undisputed; it is a legal duty in the Children Act 2004<cross-ref type="bib" refid="R1">1</cross-ref> and enshrined in the UN Convention on the Rights of a Child.<cross-ref type="bib" refid="R2">2</cross-ref> All children have the right to express themselves regarding matters that affect them and to have their wishes and views taken into account to guide their care. A failure to realise these rights in child protection proceedings can have serious implications for children&rsquo;s safety, well-being and their ability to fully participate in decisions to reflect their values, preferences and goals.<cross-ref type="bib" refid="R3">3</cross-ref></p><p>When children are experiencing abuse, they are often required to share painful and...]]></description>
<dc:creator><![CDATA[Stewart, C. E., Hayden, T., Kabilan, L., Impey, V.]]></dc:creator>
<dc:date>2025-10-24T09:00:29-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2024-328409</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2024-328409</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[My Voice Matters: improving the quality and quantity of the voice of the child captured in child protection medical assessments by introducing a visual communication toolkit]]></dc:title>
<prism:publicationDate>2025-10-24</prism:publicationDate>
<prism:section>QUALITY IMPROVEMENT SHORT REPORT</prism:section>
</item>
<item rdf:about="http://ep.bmj.com/cgi/content/short/archdischild-2024-327804v2?rss=1">
<title><![CDATA[Joint working between clinical genetics and community child health: a quality improvement project on the mainstreaming of genomics]]></title>
<link>http://ep.bmj.com/cgi/content/short/archdischild-2024-327804v2?rss=1</link>
<description><![CDATA[<sec id="s1"><st>Summary</st><p>The genomics revolution is ever evolving. We explored ways to support the different levels of genomic literacy and upskill colleagues based in our Community Child Health service.</p></sec><sec id="s2"><st>Identifying the problem</st><p>We each have 3&ndash;4 million variants in our genome and these are innocent until proven guilty.<cross-ref type="bib" refid="R1">1</cross-ref> Genomics has evolved significantly, including the use of single nucleotide polymorphism microarray, providing better resolution and whole genome sequencing in children with global developmental delay (GDD) or intellectual disability (ID). The higher diagnostic yield provided by these techniques warrants heightened collaboration between the two specialists: clinical geneticists and community paediatricians.<cross-ref type="bib" refid="R2">2</cross-ref> Parents report facing protracted uncertainties during their child&rsquo;s diagnostic journey and appreciate the value of a diagnosis but also&mdash;crucially&mdash;access to care pathways and support networks.<cross-ref type="bib" refid="R3">3</cross-ref> Additionally, children with fetal alcohol spectrum disorder can present with complex phenotypes, and the Quality Standard (QS204)<sup><cross-ref type="bib" refid="R4">4</cross-ref></sup> (2022) advises clinicians to exclude...]]></description>
<dc:creator><![CDATA[Bhatia, S., Wickramasinghe, R., Holder, M., Gunasuntharam, K.]]></dc:creator>
<dc:date>2025-10-24T09:00:28-07:00</dc:date>
<dc:identifier>info:doi/10.1136/archdischild-2024-327804</dc:identifier>
<dc:identifier>hwp:master-id:edpract;archdischild-2024-327804</dc:identifier>
<dc:publisher>Royal College of Paediatrics and Child Health</dc:publisher>
<dc:title><![CDATA[Joint working between clinical genetics and community child health: a quality improvement project on the mainstreaming of genomics]]></dc:title>
<prism:publicationDate>2025-10-24</prism:publicationDate>
<prism:section>QUALITY IMPROVEMENT SHORT REPORT</prism:section>
</item>
</rdf:RDF>